HDAC3 Activity is Essential for Human Leukemic Cell Growth and the Expression of β-catenin, MYC, and WT1
Therapy of acute myeloid leukemia (AML) is unsatisfactory. Histone deacetylase inhibitors (HDACi) are active against leukemic cells in vitro and in vivo. Clinical data suggest further testing of such epigenetic drugs and to identify mechanisms and markers for their efficacy. Primary and permanent AM...
Main Authors: | Mandy Beyer, Annette Romanski, Al-Hassan M. Mustafa, Miriam Pons, Iris Büchler, Anja Vogel, Andrea Pautz, Andreas Sellmer, Günter Schneider, Gesine Bug, Oliver H. Krämer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/10/1436 |
Similar Items
-
WT1 påverkar proliferationen för cancercellinjer troligen via reglering av c-Myc
by: Eriksson, Jonathan
Published: (2011) -
WT1 Enhances Proliferation and Impedes Apoptosis in KRAS Mutant NSCLC via Targeting cMyc
by: Chen Wu, et al.
Published: (2015-01-01) -
Epigenetic Targeting of Autophagy via HDAC Inhibition in Tumor Cells: Role of p53
by: Maria Mrakovcic, et al.
Published: (2018-12-01) -
HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice
by: Afaloniati H, et al.
Published: (2020-06-01) -
WT1 peptide vaccine in Montanide in contrast to poly ICLC, is able to induce WT1-specific immune response with TCR clonal enrichment in myeloid leukemia
by: Hongtao Liu, et al.
Published: (2018-01-01)